Clinical Trials Directory

Trials / Completed

CompletedNCT02907944

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT-IF?)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,838 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tobacco, alcohol and opioid use disorders threaten the health of HIV-infected patients. What if evidence-based counseling and medication treatments for tobacco, alcohol and opioid use disorders (herein refered to as addiction treatments) were routinely provided in HIV clinics? Implementation Facilitation is an established strategy to increase the uptake of evidence-based treatments. Our goal is to evaluate the impact of Implementation Facilitation on the use of addiction treatments in four large HIV clinics. The purpose of the WHAT-IF study is: Aim 1. Among key stakeholders, to use quantitative and qualitative (mixed) methods to identify the site-specific evidence, context and facilitation-related barriers and facilitators to the integration of addiction treatments to help tailor an Implementation Facilitation for each clinic. Aim 2. To evaluate the impact of Implementation Facilitation on: 2a: Organizational readiness to deliver addiction treatments 2b: Provider readiness to deliver addiction treatments 2c: Provision of addiction treatments 2d: Changes in organizational models of care used to deliver addiction treatments Aim 3. To evaluate the impact of Implementation Facilitation on antiretroviral therapy receipt, HIV viral suppression, VACS Index, and retention in HIV care among patients eligible for addiction treatment.

Detailed description

The Working with HIV clinics to adopt Addiction Treatments using Implementation Facilitation (WHAT IF?) study will evaluate the impact of Implementation Facilitation on the adoption of addiction treatment services in four HIV clinics. We will use a stepped wedge design . The primary comparison is of the change that occurs from the pre-implementation period to two post-implementation periods, the initial six months (evaluation) and the following six months (maintenance). This proposal will consist of three main components in each of four clinics: 1) formative evaluation with key stakeholders at each site to guide and refine the Implementation Facilitation, 2) conduct of the Implementation Facilitation and 3) an evaluation of the impact of the Implementation Facilitation on organization and provider-level readiness, provision of addiction treatments, and HIV outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALImplementation FacilitationImplementation Facilitation is an evidence-based strategy tailored to the specific needs of the clinic, designed to increase uptake of evidence based treatments for tobacco, alcohol and opioid use disorders. Will include provider education and academic detailing. * External Facilitator: Outside content expert who assists site * Local Champion: Site stakeholder who promotes change * Provider Education and Academic Detailing: Provision of unbiased peer education * Stakeholder Engagement: Aligning goals of implementation and those impacted * Tailor Program to Site: Addressing site specific needs based on Aim 1 * Performance Monitoring and Feedback: Assess implementation of screening and treatment efforts and inform site of results * Formative Evaluation: Quant. and qual. determination of impact * Establish a Learning Collaborative: Shared learning opportunities tailored to stakeholders * Program Marketing: Increase attention to availability of on-site addiction treatment services

Timeline

Start date
2016-09-01
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2016-09-20
Last updated
2023-05-08
Results posted
2023-05-08

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02907944. Inclusion in this directory is not an endorsement.